A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFα Agent(s)

This study is ongoing, but not recruiting participants.

Study NCT00299546 Information provided by Centocor, Inc.

First Received: March 3, 2006 Last Updated: April 2, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2012
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)